InsidersTradesSigma
Follow the 박셀바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 박셀바이오 has logged 2 public disclosures. Market capitalisation: €94.3bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 이제중. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
박셀바이오 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de terapias innovadoras y soluciones biológicas.